| A Far‐Red Molecular Rotor Fluorogenic Trehalose Probe for Live Mycobacteria Detection and Drug‐Susceptibility Testing N Banahene, DM Gepford, KJ Biegas, DH Swanson, YP Hsu, BA Murphy, ... Angewandte Chemie 135 (2), e202213563, 2023 | 12 | 2023 |
| Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals C De Santi, P Pucci, A Bonotti, O Melaiu, M Cipollini, R Silvestri, ... Occupational and Environmental Medicine 74 (6), 457-464, 2017 | 9 | 2017 |
| Measurement of small molecule accumulation into Diderm bacteria GM Ongwae, I Lepori, MD Chordia, BE Dalesandro, AJ Apostolos, ... ACS Infectious Diseases 9 (1), 97-110, 2022 | 8 | 2022 |
| A bifunctional chemical reporter for in situ analysis of cell envelope glycan recycling in mycobacteria AA Pohane, DJ Moore, I Lepori, RA Gordon, TO Nathan, DM Gepford, ... ACS infectious diseases 8 (11), 2223-2231, 2022 | 8 | 2022 |
| A Metabolic‐Tag‐Based Method for Assessing the Permeation of Small Molecules Across the Mycomembrane in Live Mycobacteria Z Liu, I Lepori, MD Chordia, BE Dalesandro, T Guo, J Dong, MS Siegrist, ... Angewandte Chemie 135 (20), e202217777, 2023 | 5 | 2023 |
| Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology A Corrado, R Aceto, S Miglietta, R Silvestri, I Dell’Anno, I Lepori, B Ricci, ... 3 Biotech 14 (2), 45, 2024 | 2 | 2024 |
| A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells E Barresi, C Baldanzi, M Roncetti, M Roggia, E Baglini, I Lepori, M Vitiello, ... European Journal of Medicinal Chemistry 256, 115446, 2023 | 1 | 2023 |
| PO-220 RAN, a novel and promising gene for malignant pleural mesothelioma I Dell’anno, E Barone, I Lepori, L Migliore, S Agostini, O Melaiu, ... ESMO Open 3, A106, 2018 | 1 | 2018 |
| Bioorthogonal “Click” Cycloadditions: A Toolkit for Modulating Polymers and Nanostructures in Living Systems I Lepori, Y Oz, J Im, N Ghosh, M Paul, US Schubert, S Fedeli Reactions 5 (1), 231-245, 2024 | | 2024 |
| Enhancing the anticancer activity of attenuated Listeria monocytogenes by cell wall functionalization with “clickable” doxorubicin L Poliseno, I Lepori, M Roncetti, M Vitiello, E Barresi, P Tentori, ... | | 2023 |
| Enhancing the anticancer activity of attenuated Listeria monocytogenes by cell wall functionalization with “clickable” doxorubicin I Lepori, M Roncetti, M Vitiello, E Barresi, PM Tentori, C Baldanzi, ... Research Square, 2023 | | 2023 |
| Correction to “A Bifunctional Chemical Reporter for in Situ Analysis of Cell Envelope Glycan Recycling in Mycobacteria” AA Pohane, DJ Moore, I Lepori, RA Gordon, TO Nathan, DM Gepford, ... ACS Infectious Diseases 9 (2), 388-388, 2023 | | 2023 |
| Compartment-Specific Measurement of Small Molecule Accumulation into Diderm Bacteria GM Ongwae, I Lepori, MD Chordia, BE Dalesandro, AJ Apostolos, ... bioRxiv, 2022.05. 05.489932, 2022 | | 2022 |
| Permeation Across the Mycomembrane in Live Mycobacteria MP Z Liu, I Lepori, BE Dalesandro, MD Chordia, MS Siegrist BioRxiv, 2022 | | 2022 |
| Optimization of attenuated Listeria monocytogenes cell wall chemical engineering to increase its anticancer vaccine activity and to use it as metastasis tracer I Lepori Università di Siena, 2019 | | 2019 |
| Abstract LB-282: Two different strategies of delivery CRISPR/Cas9 system to gene edit rs4644 SNP in LGALS3 gene A Corrado, I Lepori, S Miglietta, S Batoni, M Vitiello, M Evangelista, ... Cancer Research 77 (13_Supplement), LB-282-LB-282, 2017 | | 2017 |
